Data / Federal awards / NAICS 325412 / ALCHEM LABORATORIES CORPORATION
ALCHEM LABORATORIES CORPORATION: 17 federal contract awards, $-14.0 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
ALCHEM LABORATORIES CORPORATION (UEI LD2KY6H7KMQ5), Alachua, FL, received 17 federal prime contract awards with $-14.0 million obligated in fiscal years 2024 to 2027, from 1 agency under 3 NAICS codes. Its largest buyer is Department of Health and Human Services ($-14.0 million) and its largest code is NAICS 325412 Pharmaceutical Preparation Manufacturing.
The request: Every federal contract awarded under NAICS 325412, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- LD2KY6H7KMQ5UEI
- Alachua, FLLocation
- Small BusinessBusiness size
- 17Contract awards
- $-14.0 millionObligated
- 2024-01-17First action in window
- 2026-09-17Latest action
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | 13 | $2.1 million |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 2 | $0 |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 2 | $-16,078,939 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 17 | $-14,008,426 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $-15,419,852 |
| FY2025 | $406,478 |
| FY2026 | $1 million |
Contract awards
All 17 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75N91021F00001 | Department of Health and Human Services | Delivery Order | 325412 | SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (CONTINUITY FOR 66C) | $829,190 | $2,741,495 | September 20, 2021 | September 19, 2026 | Alachua, FL | usaspending.gov |
| 75N91026F00001 | Department of Health and Human Services | Delivery Order | 325412 | THE NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DISCOVERY | $600,000 | $744,016 | September 20, 2026 | September 19, 2027 | Alachua, FL | usaspending.gov |
| 75N91022F00001 | Department of Health and Human Services | Delivery Order | 325412 | SYNTHESIS OF NON-GMP SMALL MOLECULES - INCREMENTALLY FUNDED | $405,000 | $1,249,540 | June 5, 2022 | June 4, 2027 | Alachua, FL | usaspending.gov |
| 75N91024F00001 | Department of Health and Human Services | Delivery Order | 325412 | DFMC- THE PURPOSE OF THIS TASK ORDER IS TO MANUFACTURE AND DELIVER 2200 CAPSULES OF 4MG AZA-TDC (5-AZA-4-THIO-2-DEOXYCYTIDINE) | $180,220 | $180,220 | September 27, 2019 | September 30, 2024 | Alachua, FL | usaspending.gov |
| HHSN261201700020C | Department of Health and Human Services | Definitive Contract | 325412 | IGF::OT::IGF MANUFACTURE OF BULK CHEMICALS AND BULK PHARMACEUTICAL INGREDIENTS FOR PRECLINICAL AND CLINICAL STUDIES | $44,538 | $2,809,618 | August 1, 2017 | June 4, 2022 | Alachua, FL | usaspending.gov |
| HHSN261201600066C | Department of Health and Human Services | Definitive Contract | 325412 | IGF::OT::IGF NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT | $12,511 | $4,484,609 | September 20, 2016 | September 19, 2021 | Alachua, FL | usaspending.gov |
| 75N95019D00028 | Department of Health and Human Services | IDC | 541715 | CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION. | $0 | $17,891,012 | September 26, 2019 | usaspending.gov | ||
| 75N91023D00006 | Department of Health and Human Services | IDC | 325412 | ANALYSIS AND SYNTHESIS OF GMP AND NON-GMP BULK DRUGS AND PHARMACEUTICAL FORMULATIONS | $0 | $12,069,385 | April 11, 2023 | usaspending.gov | ||
| 75N93021D00002 | Department of Health and Human Services | IDC | 541715 | THE CONTRACTOR SHALL PROVIDE PRECLINICAL DEVELOPMENT SUPPORT FOR CANDIDATE PRODUCTS AND DRUG DEVELOPMENT ACTIVITIES. THE SCOPE OF WORK ENCOM | $0 | $107,274,471 | October 15, 2020 | usaspending.gov | ||
| 75N95024D00035 | Department of Health and Human Services | IDC | 325412 | IDIQ CHEMISTRY, MANUFACTURING, AND CONTROL (CMC) AND RELATED SERVICES FOR DRUG PRODUCTS | $0 | $49,885,703 | August 1, 2024 | usaspending.gov | ||
| 75N95026D00007 | Department of Health and Human Services | IDC | 325412 | EO 14398 IDIQ: CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG SUBSTANCES (TRND 1) | $0 | $49,713,679 | August 1, 2026 | usaspending.gov | ||
| 75N98026D00012 | Department of Health and Human Services | IDC | 325412 | NINDS DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) | $0 | $49,999,999 | May 4, 2026 | usaspending.gov | ||
| 75N93025D00007 | Department of Health and Human Services | IDC | 541714 | INTERVENTIONAL AGENTS CHEMISTRY SERVICES | $0 | $50,000,000 | September 15, 2024 | usaspending.gov | ||
| 75N98019D00057 | Department of Health and Human Services | IDC | 325412 | DRUG FORMULATION AND MANUFACTURING | $0 | $45,000,250 | September 27, 2019 | usaspending.gov | ||
| HHSN261201700007I | Department of Health and Human Services | IDC | 325412 | IGF::OT::IGF SYNTHESIS OF NON-GMP SMALL MOLECULES, POP: 9/18/17-9/17/22 | $0 | $7,777,665 | September 18, 2017 | usaspending.gov | ||
| 75N91022F00002 | Department of Health and Human Services | Delivery Order | 325412 | THE NON-GMP SYNTHESIS OF 100 GRAMS OF (R)-N-(6-CHLORO-4-((1-PHENYLETHYL)AMINO)PYRIDO[3,4-D]PYRIMIDIN-5-YL)METHANE-SULFONAMIDE (MTX-531) | $-946 | $42,941 | July 22, 2022 | October 21, 2022 | Alachua, FL | usaspending.gov |
| 75A50120C00078 | Department of Health and Human Services | Definitive Contract | 541714 | A MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, MULTI-ARM HISTORICAL CONTROL, COMPARATIVE TRIAL OF THE SAFETY AND EFFICACY OF HYDROXYCHLOROQUINE AND | $-16,078,939 | $4,668,079 | April 14, 2020 | August 5, 2024 | Alachua, FL | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 325412 Pharmaceutical Preparation Manufacturing
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Open opportunities under NAICS 325412
- Open opportunities under NAICS 541715
- Open opportunities under NAICS 541714
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.